Please assess the completion status of the following clinical trial:

Trial Title: RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* postoperative UICC stage Ib/II gastric carcinoma~* indication for oral chemotherapy with doxifluridine~* ECOG performance status 0 or 1~* normal liver and kidney function~Exclusion Criteria:~* inability to answer the QoL scales~* concomitant therapy with steroids or biological response modifiers~* individual hypersensitivity to mistletoe preparations~* pregnancy or lactating~* participation in another clinical trial

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- doxifluridine (Type: ACTIVE_COMPARATOR): oral chemotherapy with the 5-FU prodrug doxifluridine
- doxifluridine + mistletoe extract (Type: EXPERIMENTAL): oral chemotherapy with the 5-FU prodrug doxifluridine + mistletoe extract as subcutaneous injection

Based on this trial design, predict the completion outcome and termination type (if applicable).